SITE010-0190

SITE010 (ESP) › SITE010-0190

SITE010-0190

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE010 (ESP) · Dr. Silva
consented 2026-04-23

enrolled

AEs

4

Serious

0

Dropout signal

–

Adverse events

4

Grade 3 Constipation — outcome: RECOVERED/RESOLVED; onset 2023-02-16 (study day 112); relationship: not assessed

severe assessed

Grade 2 Alopecia — outcome: RECOVERED/RESOLVED; onset 2023-01-28 (study day 93); relationship: NOT RELATED

moderate assessed

Grade 2 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2023-01-26 (study day 91); relationship: NOT RELATED

moderate assessed

Grade 2 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2022-12-01 (study day 35); relationship: not assessed

moderate assessed

Data queries

0

No data queries. Open queries would appear here for this patient.